脂肪因子Adipsin升高与系统性硬化相关肺动脉高压的关联
该研究用多重检测法测定198例系统性硬化(SSc)患者和33名健康对照的血浆脂肪因子水平,发现Adipsin在局限皮肤型SSc中显著升高(OR 28.3),且与肺动脉高压(PAH)相关(OR 3.3),其关联强于B型利钠肽;遗传与转录组数据进一步支持Adipsin在SSc相关PAH中的潜在作用。
要点
- Adipsin在局限皮肤型SSc患者中显著升高(OR 28.3,95%CI 7.0-113.8,P<0.0001)。
- Adipsin与SSc相关PAH独立相关(OR 3.3,95%CI 1.3-8.7,P=0.02),关联强于BNP。
- Adipsin基因单核苷酸多态性及转录组表达升高均与SSc相关PAH相关。
核心结论
- Adipsin被确定为SSc相关PAH的新型脂肪组织来源标志物,循环Adipsin水平可能作为SSc的预测生物标志物。
研究设计与样本
- 研究纳入198例SSc患者和33名健康对照,采用多重检测法测定循环脂肪因子水平,并分析公开的遗传与转录组数据。
主要发现
- Adiponectin和Adipsin水平在对照组与患者间存在显著差异。
- Adipsin在局限皮肤型SSc中显著升高(OR 28.3,95%CI 7.0-113.8,P<0.0001),且与血清自身抗体状态、肺功能、心血管参数及PAH相关(OR 3.3,95%CI 1.3-8.7,P=0.02)。
- Adipsin升高与PAH的关联强于B型利钠肽。
- SSc患者中Adipsin基因单核苷酸多态性与PAH相关,转录组数据示SSc相关PAH患者Adipsin表达升高。
关键数值与推荐
- 局限皮肤型SSc与Adipsin升高的OR为28.3(95%CI 7.0-113.8,P<0.0001)。
- Adipsin与PAH的OR为3.3(95%CI 1.3-8.7,P=0.02)。
临床怎么用
- 循环Adipsin水平可能作为SSc相关PAH的预测生物标志物,尤其适用于局限皮肤型SSc患者的风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Adipose tissues secrete adipokines, peptides with potent effects modulating fibrosis, inflammation, and vascular homeostasis. Dysregulated adipose tissue biology and adipokine balance have recently been implicated in systemic sclerosis (SSc). This study was undertaken to determine whether altered circulating adipokine levels correlate with SSc disease subsets or clinical manifestations. METHODS: Multiplex assays were used to measure circulating adipokine levels in 198 patients with SSc and 33 healthy controls. Data were evaluated for correlations between serum adipokine levels and demographic and clinical features, including pulmonary arterial hypertension (PAH). To assess the relevance of adipsin, an adipokine involved in complement pathway activation, in SSc, we analyzed publicly available genetic and transcriptomic data. RESULTS: Levels of adiponectin and adipsin differed significantly between controls and patients. Adipsin was significantly elevated in patients with limited cutaneous SSc (odds ratio [OR] 28.3 [95% confidence interval (95% CI) 7.0-113.8]; P < 0.0001), and its levels were associated with serum autoantibody status, pulmonary function and cardiovascular parameters, and PAH (OR 3.3 [95% CI 1.3-8.7]; P = 0.02). Elevated adipsin was more strongly associated with PAH than B-type natriuretic peptide was. Moreover, in SSc patients, adipsin gene single-nucleotide polymorphisms were associated with PAH. Transcriptome data set analysis demonstrated elevated adipsin expression in patients with SSc-related PAH. CONCLUSION: We identify adipsin as a novel adipose tissue-derived marker of SSc-related PAH. Circulating adipsin levels might serve as predictive biomarkers in SSc. Mechanistically, adipsin might represent a pathogenic link between adipocyte dysfunction and complement pathway activation and play an important role in the pathogenesis of SSc-related PAH.
引用
- Korman BD, Marangoni RG, Hinchcliff M, et al. Brief Report: Association of Elevated Adipsin Levels With Pulmonary Arterial Hypertension in Systemic Sclerosis. Arthritis Rheumatol. 2017. PMID: 28651038. doi:10.1002/art.40193
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。